NCOA7 (Nuclear Receptor Coactivator 7) is a Protein Coding gene. Diseases associated with NCOA7 include brugada syndrome. Among its related pathways are AHR Pathway (Qiagen). GO annotations related to this gene include ligand-dependent nuclear receptor transcription coactivator activity and nuclear hormone receptor binding. An important paralog of this gene is TLDC2.Enhances the transcriptional activities of several nuclear receptors. Involved in the coactivation of different nuclear receptors, such as ESR1, THRB, PPARG and RARA.
NCoA-7 Polyclonal Antibody detects endogenous levels of NCoA-7 protein.
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB: 1:500-1:2000, IHC-p: 1:100-1:300, ELISA: 1:20000. Not yet tested in other applications.
NCoA-7 Polyclonal Antibody product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.
Find more details at http://www.abbkine.com/product/ncoa-7-polyclonal-antibody-abp53780.
bio-equip.cn
Abbkine Scientific Co., Ltd. was founded by a number of scientists and marketing experts in the field of life science in California in 2012. With growing demands from Asia Pacific, it move its headquarters to China. Combining cutting edge technology from United States with China's manufacturing engineering and cost advantages, we aim to provide innovative, high quality assay kits, recombinant proteins, antibodies and other research tools to accelerate life science fundamental research, drug discovery, etc.